Aluminum adjuvant

BIOLOGICAL2 trials

Sponsors

National Vaccine and Serum Institute, China, Xiamen University

Conditions

Anal CancerAnal Intraepithelial NeoplasiaGenital WartsNorovirus InfectionsNorwalk GastroenteritisPenile/Perianal/Perineal CancerPenile/Perineal /Perianal Intraepithelial Neoplasia

Phase 1

A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine

CompletedNCT04188691

National Vaccine and Serum Institute, ChinaNorovirus Infections, Norwalk Gastroenteritis

Start: 2019-11-28End: 2020-12-13Updated: 2021-04-22

Phase 3

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

Active, not recruitingNCT06866574

Xiamen UniversityAnal Cancer, Anal Intraepithelial Neoplasia, Genital Warts +2

Start: 2025-04-11End: 2031-09-30Target: 9300Updated: 2025-07-31